Description: Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford, the United Kingdom.
Home Page: www.physiomics.co.uk
Bee House
Oxford,
OX14 4SB
United Kingdom
Phone:
44 123 5841575
Officers
| Name | Title |
|---|---|
| Dr. Peter Joseph Sargent | CEO, COO & Director |
| Prof. David Fell | Co-Founder & Member of Scientific Advisory Board |
| Mr. Anthony Louis Clayden ACA, BSc (Hons), MSI | Head of Finance & Company Secretary |
| Ms. Hayley Close | Head of Business Development |
| Dr. Venkata Putcha | Head of Biostatistics |
| Dr. Mark Davies | Head of Quantitative Pharmacology & Data Science |
| Dr. Mark Middleton M.D., Ph.D. | Consultant & Member of Scientific Advisory Board |
| Dr. Robert Jackson Ph.D. | Consultant & Member of Scientific Advisory Board |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.4919 |
| Price-to-Sales TTM: | 3.1627 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 11 |